UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 1.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 465,672 shares of the company's stock after buying an additional 7,021 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 0.86% of Molina Healthcare worth $153,388,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MOH. Rothschild Investment LLC increased its stake in Molina Healthcare by 126.3% in the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after buying an additional 48 shares during the last quarter. Zions Bancorporation National Association UT purchased a new stake in Molina Healthcare in the 1st quarter valued at about $29,000. Deseret Mutual Benefit Administrators increased its stake in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after buying an additional 34 shares during the last quarter. Elequin Capital LP increased its stake in Molina Healthcare by 170.6% in the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock valued at $30,000 after buying an additional 58 shares during the last quarter. Finally, Silver Oak Securities Incorporated purchased a new stake in Molina Healthcare in the 1st quarter valued at about $34,000. Hedge funds and other institutional investors own 98.50% of the company's stock.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on MOH shares. UBS Group reduced their target price on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Wall Street Zen downgraded shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Morgan Stanley downgraded shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and reduced their target price for the company from $364.00 to $266.00 in a research report on Thursday, July 10th. Cantor Fitzgerald reissued a "neutral" rating and set a $210.00 target price on shares of Molina Healthcare in a research report on Tuesday, August 26th. Finally, Truist Financial reissued a "hold" rating and set a $180.00 target price (down from $335.00) on shares of Molina Healthcare in a research report on Friday, July 25th. Three equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, Molina Healthcare currently has a consensus rating of "Hold" and an average target price of $225.18.
Get Our Latest Report on Molina Healthcare
Insider Buying and Selling at Molina Healthcare
In other news, COO James Woys purchased 10,000 shares of the business's stock in a transaction on Monday, August 4th. The stock was purchased at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the acquisition, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronna Romney sold 700 shares of the firm's stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the sale, the director owned 17,131 shares in the company, valued at approximately $2,633,719.94. This trade represents a 3.93% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.
Molina Healthcare Stock Performance
MOH traded up $4.25 on Thursday, hitting $180.57. The company's stock had a trading volume of 196,208 shares, compared to its average volume of 1,023,154. The company's 50 day simple moving average is $176.00 and its 200-day simple moving average is $263.77. The firm has a market cap of $9.79 billion, a P/E ratio of 8.90 and a beta of 0.54. Molina Healthcare, Inc has a 12 month low of $151.95 and a 12 month high of $359.97. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. During the same period in the previous year, the business earned $5.86 earnings per share. The firm's revenue for the quarter was up 15.7% on a year-over-year basis. Analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.